Huse Kamencic1, Luke Thiel2, Erwin Karreman3, John Thiel4. 1. Department of Obstetrics and Gynecology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. 2. College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. 3. Department of Research and Performance Support, Regina Qu'Appelle Health Region, Regina, Saskatchewan, Canada. 4. College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Electronic address: John.thiel@usask.ca.
Abstract
STUDY OBJECTIVES: To examine the surgical indications and pathologic findings in patients undergoing a second surgery after placement of the Essure permanent birth control system to determine the role of Essure in developing new-onset pelvic pain. DESIGN: Retrospective cohort (Canadian Task Force classification II-2). SETTING: Tertiary-level hospital. PATIENTS: Women who have had Essure placement and subsequent second surgery. INTERVENTION: Charts from women undergoing pelvic surgery after Essure placement from June 2002 to June 2013 were reviewed and the indication for the procedure, surgical and pathologic findings noted. MEASUREMENTS AND MAIN RESULTS: Of 1430 patients, 62 (4.3%) had a second surgery after Essure placement, and 24 of these (1.6%) had a surgical indication not related to pain. The remaining 38 patients (2.7%) had either new-onset (n = 27) or worsening pre-existing pain (n = 11). In the new-onset pain group, 15 (1%) had surgical findings or pathology consistent with a painful gynecologic condition. In the remaining 12, 8 (0.5%) seemed to be related to some perforation or migration of the Essure device. In 4 patients (0.3%) with no other obvious cause for the new-onset pain, it was thus attributed to the Essure microinsert. CONCLUSION: Essure sterilization can be associated with new-onset pain or a worsening of a pre-existing painful gynecologic condition, although both are very rare. A careful and complete consent before placement and a thorough examination if pain does occur usually show some etiology for the pain other than the Essure insert.
STUDY OBJECTIVES: To examine the surgical indications and pathologic findings in patients undergoing a second surgery after placement of the Essure permanent birth control system to determine the role of Essure in developing new-onset pelvic pain. DESIGN: Retrospective cohort (Canadian Task Force classification II-2). SETTING: Tertiary-level hospital. PATIENTS: Women who have had Essure placement and subsequent second surgery. INTERVENTION: Charts from women undergoing pelvic surgery after Essure placement from June 2002 to June 2013 were reviewed and the indication for the procedure, surgical and pathologic findings noted. MEASUREMENTS AND MAIN RESULTS: Of 1430 patients, 62 (4.3%) had a second surgery after Essure placement, and 24 of these (1.6%) had a surgical indication not related to pain. The remaining 38 patients (2.7%) had either new-onset (n = 27) or worsening pre-existing pain (n = 11). In the new-onset pain group, 15 (1%) had surgical findings or pathology consistent with a painful gynecologic condition. In the remaining 12, 8 (0.5%) seemed to be related to some perforation or migration of the Essure device. In 4 patients (0.3%) with no other obvious cause for the new-onset pain, it was thus attributed to the Essure microinsert. CONCLUSION: Essure sterilization can be associated with new-onset pain or a worsening of a pre-existing painful gynecologic condition, although both are very rare. A careful and complete consent before placement and a thorough examination if pain does occur usually show some etiology for the pain other than the Essure insert.
Authors: Jennifer L Carey; Nathalie Nader; Peter R Chai; Stephanie Carreiro; Matthew K Griswold; Katherine L Boyle Journal: Clin Ther Date: 2017-01-07 Impact factor: 3.393
Authors: Emilie V J van Limburg Stirum; Nisse V Clark; Alexis Lindsey; Xiangmei Gu; Andreas L Thurkow; Jon I Einarsson; Sarah L Cohen Journal: JSLS Date: 2020 Jan-Mar Impact factor: 2.172